Strategic Plan Objective Detail
Interagency Autism Coordinating Committee (IACC) logo
Office of Autism Research Coordination (OARC) logo

Question 2: Long-term Objective B  

$450,271.00
Fiscal Year: 2010

Yellow dot: Objective has some degree of funding, but less than the recommended amount.2LB. Launch at least three studies which evaluate the applicability of ASD phenotype and/or biological signature findings for performing diagnosis, risk assessment, or clinical intervention by 2015. IACC Recommended Budget: $7,200,000 over 5 years.

Download 2010 Question 2: Long-term Objective B projects (EXCEL)
Note: Initial Sort is by Principal Investigator. Sorting by other columns is available by clicking on the desired column header.
Project Title Principal Investigator Institution
Functional neuroimaging of psychopharmacologic intervention for autism Dichter, Gabriel University of North Carolina at Chapel Hill
A study of autism Krieger, Abba University of Pennsylvania

Objective Cumulative Funding Table

IACC Strategic Plan Objective 2008 2009 2010 2011 2012 Total
Launch at least three studies that evaluate the applicability of ASD phenotype and/or biological signature findings for performing diagnosis, risk assessment, or clinical intervention by 2015.

IACC Recommended Budget: $7,200,000 over 5 years
N/A

2.L.B
$1,532,262
16 projects

2.L.B
$450,271
2 projects

2.L.B
$324,241
4 projects

2.L.B
$1,321,632
8 projects

$3,628,406
2.L.B. Funding: The recommended budget was partially met.

Progress: Imaging studies have developed activity signatures of the ASD brain. While more than 3 studies were launched, more funding and work in this area are needed.

Remaining Gaps, Needs and Opportunities: This objective also requires standardization of data collection and analysis methods, as well as collaboration among investigators to pool data. Increased emphasis must be placed on conducting biological evaluations of very young children at risk for ASD and on collecting biological samples from these young children, to enable research into the establishment of biomarkers or risk markers in this population.